Keybank National Association OH trimmed its holdings in Stryker Corporation (NYSE:SYK) by 2.9% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 169,828 shares of the medical technology company’s stock after selling 4,997 shares during the quarter. Keybank National Association OH’s holdings in Stryker were worth $26,296,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Several other large investors have also made changes to their positions in the company. Weatherstone Capital Management increased its position in Stryker by 21.7% in the 4th quarter. Weatherstone Capital Management now owns 2,965 shares of the medical technology company’s stock valued at $459,000 after buying an additional 528 shares in the last quarter. Public Employees Retirement System of Ohio increased its position in Stryker by 0.5% in the 4th quarter. Public Employees Retirement System of Ohio now owns 242,720 shares of the medical technology company’s stock valued at $37,583,000 after buying an additional 1,129 shares in the last quarter. Barings LLC increased its position in Stryker by 84.2% in the 4th quarter. Barings LLC now owns 22,106 shares of the medical technology company’s stock valued at $3,423,000 after buying an additional 10,107 shares in the last quarter. Trust Co. of Toledo NA OH bought a new stake in Stryker in the 4th quarter valued at about $205,000. Finally, New Mexico Educational Retirement Board increased its position in Stryker by 7.3% in the 4th quarter. New Mexico Educational Retirement Board now owns 30,959 shares of the medical technology company’s stock valued at $4,794,000 after buying an additional 2,100 shares in the last quarter. 74.71% of the stock is currently owned by institutional investors.
A number of analysts recently commented on SYK shares. Zacks Investment Research raised Stryker from a “sell” rating to a “hold” rating in a research report on Tuesday, October 24th. Robert W. Baird reaffirmed a “hold” rating and issued a $161.00 target price on shares of Stryker in a research report on Friday, October 27th. Piper Jaffray Companies reaffirmed a “buy” rating and issued a $156.00 target price on shares of Stryker in a research report on Friday, October 27th. Wells Fargo & Co boosted their target price on Stryker from $160.00 to $166.00 in a research report on Friday, October 27th. Finally, Stifel Nicolaus boosted their target price on Stryker from $158.00 to $168.00 and gave the company a “buy” rating in a research report on Friday, October 27th. Two equities research analysts have rated the stock with a sell rating, nine have assigned a hold rating and fourteen have issued a buy rating to the company’s stock. The company presently has a consensus rating of “Hold” and a consensus price target of $162.50.
Stryker (NYSE:SYK) last issued its quarterly earnings data on Tuesday, January 30th. The medical technology company reported $1.96 EPS for the quarter, topping analysts’ consensus estimates of $1.95 by $0.01. The firm had revenue of $3.47 billion during the quarter, compared to analyst estimates of $3.42 billion. Stryker had a return on equity of 24.56% and a net margin of 8.20%. The company’s revenue for the quarter was up 9.9% on a year-over-year basis. During the same period in the previous year, the company posted $1.78 EPS. sell-side analysts predict that Stryker Corporation will post 7.12 earnings per share for the current fiscal year.
The firm also recently announced a quarterly dividend, which will be paid on Monday, April 30th. Stockholders of record on Thursday, March 29th will be issued a $0.47 dividend. This represents a $1.88 annualized dividend and a dividend yield of 1.20%. The ex-dividend date is Wednesday, March 28th. Stryker’s dividend payout ratio is presently 70.15%.
In other news, VP William E. Berry, Jr. sold 1,306 shares of the company’s stock in a transaction that occurred on Thursday, February 1st. The stock was sold at an average price of $164.42, for a total value of $214,732.52. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, insider Graham A. Mclean sold 2,984 shares of the company’s stock in a transaction that occurred on Monday, February 5th. The shares were sold at an average price of $160.53, for a total value of $479,021.52. Following the completion of the transaction, the insider now directly owns 9,100 shares of the company’s stock, valued at $1,460,823. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 16,840 shares of company stock valued at $2,749,989. 7.40% of the stock is currently owned by corporate insiders.
COPYRIGHT VIOLATION WARNING: This article was originally reported by Week Herald and is the sole property of of Week Herald. If you are reading this article on another site, it was illegally stolen and reposted in violation of US and international copyright law. The original version of this article can be read at https://weekherald.com/2018/02/15/stryker-corporation-syk-stake-lessened-by-keybank-national-association-oh.html.
Stryker Company Profile
Stryker Corporation is a medical technology company. The Company offers a range of medical technologies, including orthopedic, medical and surgical, and neurotechnology and spine products. The Company’s segments include Orthopaedics; MedSurg; Neurotechnology and Spine, and Corporate and Other. The Orthopaedics segment includes reconstructive (hip and knee) and trauma implant systems and other related products.
Receive News & Ratings for Stryker Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stryker and related companies with MarketBeat.com's FREE daily email newsletter.